THERIVA BIOLOGICS INC (TOVX) Forecast, Price Target & Analyst Ratings

NYSEARCA:TOVX • US87164U5083

Current stock price

0.2307 USD
-0.03 (-10.3%)
At close:
0.2253 USD
-0.01 (-2.34%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for THERIVA BIOLOGICS INC (TOVX).

Forecast Snapshot

Consensus Price Target

Price Target
$2.55
+ 1,005.33% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.05
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$2.55
Upside
+ 1,005.33%
From current price of $0.23 to mean target of $2.55, Based on 8 analyst forecasts
Low
$1.01
Median
$2.55
High
$4.20

Price Target Revisions

1 Month
-64.29%
3 Months
-64.29%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for TOVX. The average price target is 2.55 USD. This implies a price increase of 1005.33% is expected in the next year compared to the current price of 0.2307.
The average price target has been revised downward by 64.29% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

TOVX Current Analyst RatingTOVX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

TOVX Historical Analyst RatingsTOVX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
TOVX was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about TOVX.
In the previous month the buy percentage consensus was at a similar level.
TOVX was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-31Maxim GroupUpgrade Hold -> Buy
2025-05-08Maxim GroupDowngrade Buy -> Hold
2024-11-13Maxim GroupMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.05
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
96.71%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
85.07%
EPS (3 Months)
85.07%

Next Earnings Summary

TOVX is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.05 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
TOVX revenue by date.TOVX revenue by date.
N/AN/AN/AN/A
110.11%		N/A
185.64%		N/A
94.37%		N/A
17.92%		N/A
20.66%
EBITDA
YoY % growth
TOVX ebitda by date.TOVX ebitda by date.
-40.91M-39.09M
4.45%		-26M
33.49%		-17.3M
33.46%		-15.42M
10.87%		-9.96M
35.41%		-14.18M
-42.37%		-21.29M
-50.14%		-21.296M
-0.03%		-19.29M
9.42%		-23.943M
-24.12%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
TOVX ebit by date.TOVX ebit by date.
-40.98M-39.25M
4.22%		-26.25M
33.12%		-17.57M
33.07%		-15.66M
10.87%		-10.16M
35.12%		-14.27M
-40.45%		-21.38M
-49.82%		-21.431M
-0.24%		-19.427M
9.35%		-24.051M
-23.80%		N/A
4.31%		N/A
-13.97%		N/A
36.18%		N/A
130.05%		N/A
1,600.00%		N/A
137.33%		N/A
20.87%		N/A
23.67%
Operating Margin
TOVX operating margin by date.TOVX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
TOVX eps by date.TOVX eps by date.
-4,375.00-2,537.50
42.00%		-1,487.50
41.38%		-749.96
49.58%		-232.50
69.00%		-152.50
34.41%		-52.50
65.57%		-31.75
39.52%		-29.25
7.87%		N/A
16.55%		-2.69
88.98%		N/A
92.42%		N/AN/AN/AN/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.05
96.71%		-0.05
91.05%		-0.05
88.67%		-0.05
57.41%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-2.348M
46.84%		-2.425M
81.54%		-2.714M
38.87%		-2.892M
-40.17%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

TOVX Yearly Revenue VS EstimatesTOVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
TOVX Yearly EPS VS EstimatesTOVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -1K -2K -3K -4K

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
24.38%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

THERIVA BIOLOGICS INC / TOVX Forecast FAQ

What is the average price target for THERIVA BIOLOGICS INC (TOVX) stock?

8 analysts have analysed TOVX and the average price target is 2.55 USD. This implies a price increase of 1005.33% is expected in the next year compared to the current price of 0.2307.

Can you provide the upcoming earnings date for THERIVA BIOLOGICS INC?

THERIVA BIOLOGICS INC (TOVX) will report earnings on 2026-05-12.

Can you provide the consensus estimates for THERIVA BIOLOGICS INC next earnings?

The consensus EPS estimate for the next earnings of THERIVA BIOLOGICS INC (TOVX) is -0.05 USD and the consensus revenue estimate is 0 USD.